270 related articles for article (PubMed ID: 31102503)
21. MiR-874 alleviates renal injury and inflammatory response in diabetic nephropathy through targeting toll-like receptor-4.
Yao T; Zha D; Gao P; Shui H; Wu X
J Cell Physiol; 2018 Jan; 234(1):871-879. PubMed ID: 30171701
[TBL] [Abstract][Full Text] [Related]
22. Involvement of miR-27a-3p in diabetic nephropathy via affecting renal fibrosis, mitochondrial dysfunction, and endoplasmic reticulum stress.
Wu L; Wang Q; Guo F; Ma X; Wang J; Zhao Y; Yan Y; Qin G
J Cell Physiol; 2021 Feb; 236(2):1454-1468. PubMed ID: 32691413
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-27a promotes podocyte injury via PPARγ-mediated β-catenin activation in diabetic nephropathy.
Zhou Z; Wan J; Hou X; Geng J; Li X; Bai X
Cell Death Dis; 2017 Mar; 8(3):e2658. PubMed ID: 28277542
[TBL] [Abstract][Full Text] [Related]
24. Dopamine 1 receptor activation protects mouse diabetic podocytes injury via regulating the PKA/NOX-5/p38 MAPK axis.
Shao X; Zhang X; Hu J; Gao T; Chen J; Xu C; Wei C
Exp Cell Res; 2020 Mar; 388(2):111849. PubMed ID: 31954110
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of Linc 4930556M19Rik Suppresses High Glucose-Triggered Podocyte Apoptosis, Fibrosis and Inflammation via the miR-27a-3p/Metalloproteinase 3 (TIMP3) Axis in Diabetic Nephropathy.
Fan H; Zhang W
Med Sci Monit; 2020 Sep; 26():e925361. PubMed ID: 32896839
[TBL] [Abstract][Full Text] [Related]
26. MiR-30c protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition in db/db mice.
Zhao Y; Yin Z; Li H; Fan J; Yang S; Chen C; Wang DW
Aging Cell; 2017 Apr; 16(2):387-400. PubMed ID: 28127848
[TBL] [Abstract][Full Text] [Related]
27. NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice.
Zhang L; Li R; Shi W; Liang X; Liu S; Ye Z; Yu C; Chen Y; Zhang B; Wang W; Lai Y; Ma J; Li Z; Tan X
Br J Pharmacol; 2013 Sep; 170(2):426-39. PubMed ID: 23826864
[TBL] [Abstract][Full Text] [Related]
28. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
[TBL] [Abstract][Full Text] [Related]
29. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway.
Yang H; Xie T; Li D; Du X; Wang T; Li C; Song X; Xu L; Yi F; Liang X; Gao L; Yang X; Ma C
Mol Metab; 2019 May; 23():24-36. PubMed ID: 30862474
[TBL] [Abstract][Full Text] [Related]
30. Paecilomyces cicadae-fermented Radix astragali activates podocyte autophagy by attenuating PI3K/AKT/mTOR pathways to protect against diabetic nephropathy in mice.
Yang F; Qu Q; Zhao C; Liu X; Yang P; Li Z; Han L; Shi X
Biomed Pharmacother; 2020 Sep; 129():110479. PubMed ID: 32768963
[TBL] [Abstract][Full Text] [Related]
31. Icariin alleviates diabetic renal interstitial fibrosis aggravation by inhibiting miR-320a-3p targeting BMP6.
Wang K; Hou M; Qiao C; Duan Y; Tao R; Wang X; Xiao K; Liu S; Zhao H; Wang J; Jia Z; Ding X
J Pharmacol Sci; 2024 Apr; 154(4):316-325. PubMed ID: 38485350
[TBL] [Abstract][Full Text] [Related]
32. RhoA protects the podocytes against high glucose-induced apoptosis through YAP and plays critical role in diabetic nephropathy.
Huang Z; Peng Y; Yu H; Yu X; Zhou J; Xiao J
Biochem Biophys Res Commun; 2018 Oct; 504(4):949-956. PubMed ID: 30220545
[TBL] [Abstract][Full Text] [Related]
33. Repression of miR-217 protects against high glucose-induced podocyte injury and insulin resistance by restoring PTEN-mediated autophagy pathway.
Sun J; Li ZP; Zhang RQ; Zhang HM
Biochem Biophys Res Commun; 2017 Jan; 483(1):318-324. PubMed ID: 28017719
[TBL] [Abstract][Full Text] [Related]
34. NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy.
Du P; Fan B; Han H; Zhen J; Shang J; Wang X; Li X; Shi W; Tang W; Bao C; Wang Z; Zhang Y; Zhang B; Wei X; Yi F
Kidney Int; 2013 Aug; 84(2):265-76. PubMed ID: 23594678
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of miR-34c inhibits high glucose-induced apoptosis in podocytes by targeting Notch signaling pathways.
Liu XD; Zhang LY; Zhu TC; Zhang RF; Wang SL; Bao Y
Int J Clin Exp Pathol; 2015; 8(5):4525-34. PubMed ID: 26191142
[TBL] [Abstract][Full Text] [Related]
36. MiR-770-5p facilitates podocyte apoptosis and inflammation in diabetic nephropathy by targeting TIMP3.
Wang L; Li H
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32309847
[TBL] [Abstract][Full Text] [Related]
37. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
[TBL] [Abstract][Full Text] [Related]
38. miR-218 regulates diabetic nephropathy via targeting IKK-β and modulating NK-κB-mediated inflammation.
Li M; Guo Q; Cai H; Wang H; Ma Z; Zhang X
J Cell Physiol; 2020 Apr; 235(4):3362-3371. PubMed ID: 31549412
[TBL] [Abstract][Full Text] [Related]
39. Protein S Protects against Podocyte Injury in Diabetic Nephropathy.
Zhong F; Chen H; Xie Y; Azeloglu EU; Wei C; Zhang W; Li Z; Chuang PY; Jim B; Li H; Elmastour F; Riyad JM; Weber T; Chen H; Wang Y; Zhang A; Jia W; Lee K; He JC
J Am Soc Nephrol; 2018 May; 29(5):1397-1410. PubMed ID: 29511111
[No Abstract] [Full Text] [Related]
40. MiR-33a Overexpression Exacerbates Diabetic Nephropathy Through Sirt6-dependent Notch Signaling.
Wang Y; Dai S; Yang J; Ma J; Wang P; Zhao X; Liu J; Xiao A; Song Y; Gao L
Iran J Kidney Dis; 2024 May; 18(3):168-178. PubMed ID: 38904337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
